Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
Recruiting · NCT06893380 · Registry updated 2025-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm | Recruiting | Not stated | 2025-09-15 | NCT06893380 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CHA University | 16 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHA Bundang Medical Center | Seongnam-si | South Korea | 18 |